Another investigation identified that circ_0001598 promoted TZB resistance by modulating the miR-1184/programmed death-ligand 1 (PD-L1) signaling pathway in HER2-positive BC (Huang et al., 2021). The gene discussed is ERBB2; the disease is breast cancer.